Share

Networks

Clinical Studies (2)

  • NIRSE-GAL : Study aims to evaluate the impact of nirsevimab in preventing RSV in healthy infants and high-risk children less than 24 months of age at the start of RSV season in Galicia
  • PRIPASCO : Study aims to estimate the annual symptomatic incidence of Bordetella pertussis and RSV infections in patients aged 18 years and over with asthma

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Children (1-11 years)
  • Hospital
  • Outpatient clinic
  • Primary care
  • Respiratory syncytial virus
  • Bordetella pertussis
  • Respiratory syncytial virus infection
  • Pertussis
  • Blood sample
  • Nasopharyngeal swab
  • Pharmacological intervention
  • Monoclonal antibodies
  • Nirsevimab

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to